Skip to content
AwardedSpainGoods

Suministro por exclusividad del fármaco BREXUCABTAGEN AUTOLEUCEL, medicamento TECARTUS® con destino a la Farmacia Hospitalaria del Área de Salud de Badajoz

Published
Published 12 June 2026

Overview

The Badajoz Health Area procured an exclusive supply of BREXUCABTAGEN AUTOLEUCEL (TECARTUS®) pharmaceutical for its hospital pharmacy. GILEAD SCIENCES, S.L. was awarded the contract on 15 May 2026 for €242,404.16.

Key details

Country
Spain
Status
Awarded
Category
Goods
Procedure
Direct
Published
12 June 2026
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
€242,404
Award date
15 May 2026
Winner
  • GILEAD SCIENCES, S.L.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    12 June 2026

Contracting authority

  • Gerencia del Área de Salud de Badajoz

    Procuring entity

    Badajoz, Spain

    ID_PLATAFORMA: 20994060143166

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Suministro por exclusividad del fármaco BREXUCABTAGEN AUTOLEUCEL, medicamento TECARTUS® con destino a la Farmacia Hospitalaria del Área de Salud de Badajoz — won by GILEAD SCIENCES, S.L. — Skim